Research Paper Volume 13, Issue 20 pp 23810—23830
CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer
Figure 2. GSEA results show that CCR5 is positively correlated with NF-κB pathway (A), TCR pathway (B), TH1/TH2 pathway (C), Natural killer cell up (D), immune checkpoint signature (E) and Apoptosis (F).